Kobe Minimally Invasive Cancer Center /ID# 277469

Kobe, Hyōgo 650-0046

1 studies enrolling now · 1 studies all time

What they study most

Non-Small Cell Lung Cancer

Studies at this site

• A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Recruiting now